
Reset all filters
01 6APOTEX INC
02 6AURO PHARMA INC
03 6LABORATOIRE RIVA INC.
04 6MINT PHARMACEUTICALS INC
05 6NORA PHARMA INC
06 10OTSUKA PHARMACEUTICAL CO LTD
07 6PHARMASCIENCE INC
08 6PRO DOC LIMITEE
09 15Pharmascience Inc.
10 6SANDOZ CANADA INCORPORATED
11 6SANIS HEALTH INC
12 6SIVEM PHARMACEUTICALS ULC
Reset all filters
01 70ARIPIPRAZOLE
02 15Aripiprazole
Reset all filters
01 1KIT
02 1POWDER FOR SUSPENSION, SUSTAINED-RELEASE
03 2SUSPENSION (EXTENDED-RELEASE)
04 81TABLET
Reset all filters
01 6ABILIFY
02 2ABILIFY ASIMTUFII
03 2ABILIFY MAINTENA
04 6APO-ARIPIPRAZOLE
05 18ARIPIPRAZOLE
06 6AURO-ARIPIPRAZOLE
07 6MINT-ARIPIPRAZOLE
08 6NRA-ARIPIPRAZOLE
09 6PMS-ARIPIPRAZOLE
10 6RIVA-ARIPIPRAZOLE
11 6SANDOZ ARIPIPRAZOLE
12 15Blank
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Canada